Vallejo A, Abad-Fernández M, Moreno S, Moreno A, Pérez-Elías M J, Dronda F, Casado J L
Department of Infectious Diseases, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University Hospital Ramón y Cajal, Ctra Colmenar Km 9, 28034, Madrid, Spain,
Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):267-75. doi: 10.1007/s10096-014-2229-1. Epub 2014 Aug 21.
Visceral leishmaniasis (VL) in HIV-1-infected patients has been associated with poor immunological recovery and frequent disease relapses. The aim of this study was to analyse the role of T cell populations, Treg cells and CCR5 density in patients with VL compared to HIV-1-infected patients without leishmaniasis. A cross-sectional study of nine Leishmania-HIV-1-coinfected (LH) patients with VL receiving suppressive cART for at least 1 year were compared to 16 HIV-1-infected patients with non-immunological response (NIR, CD4 count below 250 cells/mm(3)) and 26 HIV-1-infected patients with immunological response (IR, CD4 count above 500 cells/mm(3)) without leishmaniasis. LH patients had a deep depletion of naïve T cells (p = 0.002), despite similar levels of effector T cells compared to NIR patients. CD4 Treg cells were similar compared to NIR patients, but higher compared to IR patients (p < 0.001). Interestingly, CD4 Treg CTLA-4(+) cells were higher in LH patients compared to either NIR or IR patients (p = 0.022 and p < 0.001, respectively), and the CD4 Treg/TEM ratio was similar to NIR patients, but higher compared to IR patients (p = 0.017). CCR5(+) T cell levels were higher compared to IR patients (p < 0.001), while CCR5 density on T cells were higher compared to both NIR and IR patients (p < 0.005 in both cases). Higher levels of CD4(+) CTLA-4(+) Treg cells and CCR5 density on CD8(+) T cells are strongly associated with VL in HIV-1-infected patients. Also, these patients have a poor immunological profile that might explain the persistence and relapse of the pathogen.
内脏利什曼病(VL)在HIV-1感染患者中与免疫恢复不佳和疾病频繁复发有关。本研究的目的是分析与未患利什曼病的HIV-1感染患者相比,VL患者中T细胞群体、调节性T细胞(Treg细胞)和CCR5密度的作用。对9例接受至少1年抑制性抗逆转录病毒治疗(cART)的利什曼原虫-HIV-1合并感染(LH)且患有VL的患者进行了横断面研究,并与16例无免疫应答(NIR,CD4细胞计数低于250个细胞/mm³)的HIV-1感染患者以及26例无利什曼病的有免疫应答(IR,CD4细胞计数高于500个细胞/mm³)的HIV-1感染患者进行比较。尽管与NIR患者相比效应T细胞水平相似,但LH患者的初始T细胞深度耗竭(p = 0.002)。与NIR患者相比,CD4 Treg细胞相似,但与IR患者相比更高(p < 0.001)。有趣的是,与NIR或IR患者相比,LH患者的CD4 Treg CTLA-4(+)细胞更高(分别为p = 0.022和p < 0.001),且CD4 Treg/TEM比值与NIR患者相似,但与IR患者相比更高(p = 0.017)。与IR患者相比,CCR5(+) T细胞水平更高(p < 0.001),而T细胞上的CCR5密度与NIR和IR患者相比均更高(两种情况均为p < 0.005)。HIV-1感染患者中较高水平的CD4(+) CTLA-4(+) Treg细胞和CD8(+) T细胞上的CCR5密度与VL密切相关。此外,这些患者的免疫状况不佳,这可能解释了病原体的持续存在和复发。